USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Ert
Address:
9653 Featherwood Lane
Spring Valley, OH 45370
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
2
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $413,605.00 8
SBIR Phase II $1,506,598.00 4

Award List:

ADENOSINE DEAMINASE (ADA) AND PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) DEFICIENCIES ARE ASSOCIATED WITH CERTAINIMMUNODEFICIENCIES IN HUMANS.

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$34,612.00
Agency:
HHS
Principal Investigator:
Abraham abuchowski , PRINCIPAL INVESTIGATOR
Abstract:
Adenosine deaminase (ada) and purine nucleoside phosphorylase (pnp) deficiencies are associated with certainimmunodeficiencies in humans. enzon will use patented methodology to prepare therapeutic modifications of ada and pnp. the procedure consists of attachment of monomethoxypolyethylene glycol… More

CYANIDE IS A RAPIDLY ACTING POISON THAT AFFECTS RESPIRATION IN BIOLOGICAL SYSTEMS.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$78,625.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Frank f davis
Abstract:
Cyanide is a rapidly acting poison that affects respiration in biological systems. victims may die in minutes. enzon, inc. is the exclusive licensee for a patented process for the chemical modification of enzymes that greatly extend their blood circulating life, eliminates or minimizes… More

THERAPEUTIC ENZYMES FOR DISEASES INVOLVING ACTIVE OXYGEN

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$46,800.00
Agency:
HHS
Principal Investigator:
Abraham Abuchowski , Principal Investigator
Abstract:
N/a

THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP A THERA- PEUTIC URICASE THAT CAN BE USED IN HYPERURICEMIA AND THE VARIOUS MANIFESTATIONS OF GOUT, INCLUDING ACUTE AND CHRONIC GOUTY ARTHRITIS TOPHI AND URATE DEPOSITS IN TISSUES AND ORGANS, AND URIC ACID

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$43,000.00
Agency:
HHS
Principal Investigator:
Abraham abuchowski , PRINCIPAL INVESTIGATOR
Abstract:
The long-term goal of this project is to develop a thera- peutic uricase that can be used in hyperuricemia and the various manifestations of gout, including acute and chronic gouty arthritis tophi and urate deposits in tissues and organs, and uric acid nephropathy. it is expected that the… More

CYTOMEGALOVIRUS DETECTION USING NONRADIOACTIVE DNA PROBES IN SITU

Award Year / Program / Phase:
1986 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
John A Todd , Principal Investigator
Abstract:
N/a

CYTOMEGALOVIRUS DETECTION USING NONRADIOACTIVE DNA PROBES IN SITU

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$214,000.00
Agency:
HHS
Principal Investigator:
John A Todd , Principal Investigator
Abstract:
Cytomegalovirus (cmv), a member of the herpes virus group, is present in the blood of a large portion of the human population. administration of this blood to high-risk patients may result in death. enzo proposes the developmentof a quick, specific, easy and economical diagnostic test, based on… More

AMINO ACID-DEGRADING ENZYMES AS ANTICANCER AGENTS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$47,000.00
Agency:
HHS
Principal Investigator:
Frank f davis phd
Abstract:
Enzon, inc. is involved in the development of therapeutic enzymes for human and veterinary use. many enzymes have shown effectiveness as anticancer agents on initial injection, but their immunogenicity and short plasma half-life have prevented exploitation of their potential. enzon, inc. will modify… More

THERAPEUTIC ENZYMES FOR DISEASES INVOLVING ACTIVE OXYGEN

Award Year / Program / Phase:
1988 / SBIR / Phase II
Award Amount:
$444,000.00
Agency:
HHS
Principal Investigator:
Abraham Abuchowski , Principal Investigator
Abstract:
Active oxygen species are implicated in many diseases. enzon is improving the therapeutic effectiveness of superoxide dismutase and catalase by our patented process so that these active oxygen-scavenging enzymes can be used routinely against active oxygen induced or exacerbated pathologies. the… More

CRYSTALLOGRAPHIC AREAR DETECTOR SOFTWARE

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
NSF
Principal Investigator:
Andrew howard , PRINCIPAL INVESTIGATOR
Abstract:
N/a

CRYSTALLOGRAPHIC AREAR DETECTOR SOFTWARE

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$250,000.00
Agency:
NSF
Principal Investigator:
Andrew howard , PRINCIPAL INVESTIGATOR
Abstract:
N/a

Assessment and Rejuvenation of Thermomechanical Fatigue Damaged Metal Matrix Composite Components

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$63,568.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr. Jalees Ahmad
Abstract:
N/a

Assessment and Rejuvenation of Thermomechanical Fatigue Damaged Metal Matrix Composite Components

Award Year / Program / Phase:
1996 / SBIR / Phase II
Award Amount:
$598,598.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr. Jalees Ahmad
Abstract:
The proposed effort is aimed at developing dual use concepts and techniques for use in rejuvenation of MMC components which contain classical creep-fatigue damage due to thermomechanical service loading and environment. Additionally, the research will include assessment of as manufactured MMC… More